Table 4. Clinical efficacy of frequency marker (f-marker).
| Frequency | Frequency ratio | Count | P-value | AUC | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| f(N) | f(P) | Control group | Patient group | ||||||||
| Positive f-marker | 26% | 72% | 2.8 | ||||||||
| 49% | 88% | 1.8 | |||||||||
| 23% | 63% | 2.7 | |||||||||
| 49% | 77% | 1.6 | |||||||||
| 14% | 56% | 4.0 | 2.3 | ± | 1.8 | 5.4 | ± | 2.7 | 7.81.E-09 | 0.82 | |
| 33% | 70% | 2.1 | |||||||||
| 7% | 37% | 5.3 | |||||||||
| 9% | 33% | 3.5 | |||||||||
| 16% | 47% | 2.9 | |||||||||
| Negative f-marker | 79% | 26% | 3.1 | ||||||||
| 74% | 44% | 1.7 | |||||||||
| 63% | 26% | 2.5 | |||||||||
| 40% | 7% | 5.7 | |||||||||
| 86% | 42% | 2.1 | |||||||||
| 56% | 28% | 2.0 | 7.7 | ± | 3.1 | 3.6 | ± | 3.8 | 6.31.E-07 | 0.79 | |
| 86% | 53% | 1.6 | |||||||||
| 91% | 53% | 1.7 | |||||||||
| 60% | 30% | 2.0 | |||||||||
| 60% | 23% | 2.6 | |||||||||
| 72% | 30% | 2.4 | |||||||||
f(N), frequency in control group; f(P), frequency in gastric cancer patient group; Count, numbers of f-markers in each sample; AUC, area under the curve.